RedHill Biopharma reported $-1.54M in Net Income for its fiscal quarter ending in June of 2024.





Net Income Change Date
Clal Biotechnology ILS -6.17M 15.56M Dec/2022
Compugen USD -6.98M 360K Sep/2025
Cronos Group USD -25.96M 13.75M Sep/2025
RedHill Biopharma USD -1.54M 0 Jun/2024